300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Cryptocurrency
Digital Media
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Facebook
Blockchain
Theatre
Beauty
Fashion
Infrastructure
Medical
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Web3
Recruiting
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Russian Federation
Lesotho
Nepal
Pakistan
Turkey
Mexico
Tajikistan
Sweden
Zambia
Liberia
Oman
Romania
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Sri Lanka
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Botswana
Seychelles
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Sierra Leone
Philippines
Portugal
El Salvador
Senegal
India
Canada
Germany
Ireland
Saudi Arabia
Kenya
Mali
Malaysia
Rwanda
Latvia
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Qatar
Barbados
Belgium
Azerbaijan
Austria
Ethiopia
Jordan
Bahamas
Ecuador
Bulgaria
Bolivia
Belize
Algeria
Belarus
Finland
Bahrain
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Jersey
Estonia
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Haibang Capital, VC Fund

Haibang Capital

VC Fund

Hangzhou, China

Haibang Capital is a VC fund in Hangzhou focused on Health Care and Biotechnology. Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.

Total investments:
50
Last investment:
Lead investor:
20%
Last fund:

Last updated:

Industries Haibang Capital invests in

Health CareBiotechnologyManufacturingMedicalMedical Device

Stages Haibang Capital invests in

Series ASeries BAngelSeries CSeed

Countries Haibang Capital invests in

China

Round sizes

Angel $435k–$2.8MSeries A $1.5M–$15MSeries B $10M–$79M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Angel
$435k–$2.8M
Series A
$1.5M–$15M
Series B
$10M–$79M

Investment Focus

Industry

  • Health Care 13 (26%)
  • Biotechnology 13 (26%)
  • Manufacturing 12 (24%)
  • Medical 8 (16%)
  • Medical Device 8 (16%)
See all 47 industries →

Stage

  • Series A 21 (42%)
  • Series B 9 (18%)
  • Angel 7 (14%)
  • Series C 5 (10%)
  • Seed 4 (8%)
See all 7 stages →

Team

NameTitleInvestmentsLinksEmail
Gang Liang
Gang Liang Founding Partner
Founding Partner Total investments: 0
Find email
Li Xie
Li Xie President
President Total investments: 0 Find email
Naxin Yao
Naxin Yao Chairman & Executive Partner
Chairman & Executive Partner Total investments: 0 Find email
MD Total investments: 2 Find email

Investments

CompanyDescriptionRoundLinks
MatriQ
Series A / Aug 20, 2026
Hopstem is a Hangzhou-based pharmaceutical company, engaged in human iPSCs/ESCs neural differentiation, cell banking, and cell engineering. $29.6M / Series C / Aug 10, 2026
Hongde New Materials Hongde New Materials
Hongde New Materials produces thermoplastic composite materials with fiber reinforcement. It offers energy storage and auxiliary components for solar and automobile power and steering systems. $14.8M / Series A / Aug 05, 2026
Wuwen Zhixing is an intelligent driving service provider dedicated to offering professional and cutting-edge integrated solutions for AI data and simulation verification, as well as developing AI data infrastructure and accelerators. $14.6M / Seed / Apr 24, 2026
XPTC is a wafer slicing equipment developer, dedicated to the research, development, production, and sales of ultra-precision thinning cutting equipment and related consumables. $56.4M / Venture - Series Unknown / Dec 08, 2025
Sanctuary Bio is a DNA damage repair drug developer, focusing on the field of DNA damage repair. $14.1M / Series A / Dec 08, 2025
Veminsyn is a biotech manufacturing firm that conducts research and produces healthcare and agricultural products. Series B / Sep 29, 2025
Jinggou Biotech
Jinggou Biotech is a technology-driven company that focuses on synthetic biology research and development. Seed / Aug 20, 2025
Huashen Ruili Huashen Ruili
Huashen Ruili is a manufacturer and retailer of auto parts. It focuses on the advancement of drive motor systems' dry brake-by-wire technology. Seed / Jul 15, 2024
Jianxin Jiaren
Jianxin Jiaren is a manufacturing business that creates and markets chemical products and raw materials. It uses a chemical recycling system, discarded waste textiles, and uses chemical decomposition technology to reduce waste polyester materials into small chemical molecules. It reduces dependence on petroleum resources and waste generation. $13.8M / Series A / Jun 03, 2024
See all 50 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Construction
Mobile
Photography
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Cryptocurrency
Digital Media
Oil and Gas
Film
Retail
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Facebook
Blockchain
Theatre
Beauty
Fashion
Infrastructure
Medical
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Web3
Recruiting
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Russian Federation
Lesotho
Nepal
Pakistan
Turkey
Mexico
Tajikistan
Sweden
Zambia
Liberia
Oman
Romania
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Kuwait
Czech Republic
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Sri Lanka
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Botswana
Seychelles
Paraguay
France
South Africa
Denmark
Georgia
Ghana
Iraq
Sierra Leone
Philippines
Portugal
El Salvador
Senegal
India
Canada
Germany
Ireland
Saudi Arabia
Kenya
Mali
Malaysia
Rwanda
Latvia
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Qatar
Barbados
Belgium
Azerbaijan
Austria
Ethiopia
Jordan
Bahamas
Ecuador
Bulgaria
Bolivia
Belize
Algeria
Belarus
Finland
Bahrain
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Jersey
Estonia
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Haibang Capital invest in?

Haibang Capital invests primarily in Health Care, Biotechnology and Manufacturing startups, most often at Series A and Series B stage. Most of the 50 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does Haibang Capital invest in?

Haibang Capital typically joins rounds of $435k–$2.8M at Angel, $1.5M–$15M at Series A and $10M–$79M at Series B. These are whole funding-round sizes, not Haibang Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Haibang Capital took part in.

How do I contact Haibang Capital?

Public channels for Haibang Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Haibang Capital?

The team at Haibang Capital includes Gang Liang (Founding Partner), Li Xie (President) and Naxin Yao (Chairman & Executive Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Haibang Capital Haibang Capital Find emails